Related Experiment Videos
Terlipressin infusion in catecholamine-resistant shock.
D H Jolley1, B L De Keulenaer, A Potter
1Intensive Care Unit, Royal Darwin Hospital, Darwin, Northern Territory.
Anaesthesia and Intensive Care
|November 7, 2003
Summary
Continuous terlipressin infusion effectively treated catecholamine-resistant shock in intensive care. This vasopressor analogue demonstrated significant improvement, offering a novel therapeutic approach for critical care patients.
Area of Science:
- Critical Care Medicine
- Pharmacology
Background:
- Catecholamine-resistant shock is a frequent challenge in intensive care units.
- Terlipressin, a vasopressin analogue, has shown success in bolus doses for managing this condition.
- Potential mechanisms include addressing vasopressin deficiency and restoring vascular tone.
Observation:
- A case report details the successful use of a continuous terlipressin infusion.
- The patient experienced a dramatic improvement in their clinical status.
Findings:
- Continuous terlipressin infusion represents a novel treatment strategy for catecholamine-resistant shock.
- This approach may offer advantages over traditional bolus administration.
Implications:
- This case suggests continuous terlipressin infusion could be a viable option for refractory shock.
- Further research is warranted to explore its efficacy and safety in a broader patient population.